R. Naidu et al., IMMUNOHISTOCHEMICAL ANALYSIS OF CATHEPSIN-D EXPRESSION IN PRIMARY BREAST CARCINOMAS, Journal of tumor marker oncology, 13(4), 1998, pp. 37-47
Cathepsin-D is a lysosomal protease implicated in cancer metastases an
d its association in breast carcinomas appears to be of prognostic sig
nificance. In the present study expression of cathepsin-D was evaluate
d in 134 primary breast carcinomas fixed in formalin and paraffin embe
dded using immunohistochemical technique. Expression of cathepsin-D wa
s analyzed in relation to clinico-pathological parameters and tumor ma
rkers such as epidermal growth factor receptor (EGFR), c-erbB2 and p53
. Overexpression of cathepsin-D was detected in 54% of comedo ductal c
arcinoma in situ (DCIS), 65% of invasive ductal carcinomas, 71% of car
cinomas containing both the in situ and invasive lesions and 20% of in
vasive lobular carcinomas. Significant: association was observed betwe
en strong immunopositivity of cathepsin-D and lymph node status, high
histological grade and EGFR but not with estrogen receptor, age of pat
ient, c-erbB2 and p53. These observations suggest that overexpression
of cathepsin-D in noninvasive, noninvasive and invasive in the same le
sions and invasive carcinomas indicates that cathepsin-D may be involv
ed in promoting tumor invasion. Its association with lymph node metast
ases, high tumor grade and EGFR shows that cathepsin-D may have potent
ial to be an indicator for poor prognosis.